总部位于圣地亚哥的制药公司Gossamer Bio, Inc. (GOSS)今日宣布，其已重新符合纳斯达克最低竞价要求，解决了其在纳斯达克全球精选市场持续上市的问题。该公司股票目前交易价格为$1.42，过去六个月涨幅达47.86%。

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

The Gossamer-1 project is concerned with the development and establishment of a space-qualified technology for the deployment of ultra-light, large foil structures in space. The core technologies are ...

SAN DIEGO, CA – Gossamer Bio, Inc. (GOSS), a pharmaceutical company based in San Diego, announced today that it has regained compliance with the Nasdaq's minimum bid price requirement ...

In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other best penny stocks to buy according to the media. On December 24, Global Advisors ...

Overview: Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension in the ...

I love when dramatic fluttery eyelashes make an appearance on the runway, but the fall 2025 Thom Browne show took eye makeup ...